Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Behav Health Serv Res ; 2023 Apr 27.
Article in English | MEDLINE | ID: covidwho-2297899

ABSTRACT

During the initial COVID-19 surge, one public hospital in NYC updated their post-discharge outreach approach for patients with substance use disorder, as part of the CATCH (Consult for Addiction Treatment and Care in Hospitals) program. Beginning April 1, 2020, three peers and two addiction counselors attempted telephonic outreach to patients who received a CATCH consultation during hospitalization from program launch (October 7, 2019) through March 31, 2020 (n = 329). Outreach calls could include counseling, in-depth peer support, and referrals to substance use services (SUS)-a significant expansion of the services offered via outreach pre-pandemic. CATCH staff successfully reached 29.5% of patients and provided 77.6% of them with supportive counseling and referrals. Thirty percent of unsuccessful calls were due to inactive numbers, and only 8% of patients without housing were reached. Telephonic outreach established a low-barrier connection between patients and SUS that may be valuable during any period, including non-COVID times. Future interventions that address social determinants such as housing and cell phone access concomitantly with substance use should be considered by addiction consultation services to potentially reduce acute care utilization and improve health outcomes.

2.
Subst Use Misuse ; 57(8): 1322-1327, 2022.
Article in English | MEDLINE | ID: covidwho-1864846

ABSTRACT

OBJECTIVE: The objective of this study is to examine differences between; telehealth and in-person visits during COVID-19 and in a pre-COVID-19 reference period; COVID-19 televisit completion for patients with varying engagement in treatment during the reference period. METHODS: Electronic medical record data were collected and analyzed with chi-squared or t-tests to compare patient demographics. Generalized estimating equations for estimating the odds of outcomes were used, controlling for demographics. RESULTS: Patients were 3.34 and 1.74 times more likely to complete a telehealth visit (n = 11,839) compared with an in-person visit during (n = 7,917) and prior (n = 15,497) to COVID-19. For patients on buprenorphine, patients with no prior in-person visits during the pre-televisit period were 2.26 more likely to complete televisits compared with patients with two or more prior in-person visits. For all patients, those with two or more prior in-person visits in the reference period were 1.27 times more likely to complete a televisit compared with a patient with no in-person visits during the pre-televisit period. There was no significant difference when comparing with patients who had only one prior in-person visit to those patients with no prior visits. CONCLUSIONS: In this study, outpatient substance use disorder (SUD) telehealth appointments were associated with higher odds of visit completion compared with in-person visits during and prior to COVID-19. Patients receiving buprenorphine, without prior in person visits, were more likely to attend if they did not have in-person visits prior to COVID-19. Regulators should consider permanently adopting telehealth flexibilities for SUD treatment once the federal emergency status has ended.


Subject(s)
Buprenorphine , COVID-19 , Substance-Related Disorders , Telemedicine , Buprenorphine/therapeutic use , Hospitals, Public , Humans , SARS-CoV-2 , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , United States/epidemiology
3.
Psychiatr Serv ; 72(6): 708-711, 2021 06.
Article in English | MEDLINE | ID: covidwho-1140398

ABSTRACT

OBJECTIVE: This study aimed to examine differences in completion rates between telepsychiatry and in-person visits during the COVID-19 pandemic and a prior reference period. METHODS: The authors used electronic medical record data along with chi-squared or t tests to compare patients' demographic characteristics. Generalized estimating equations for estimating the odds of primary and secondary outcomes were used, controlling for demographic characteristics. RESULTS: During COVID-19, the odds of completing a telepsychiatry visit (N=26,715) were 6.68 times the odds of completing an in-person visit (N=11,094). The odds of completing a telepsychiatry visit during COVID-19 were 3.00 times the odds of completing an in-person visit during the pre-COVID-19 reference period (N=40,318). CONCLUSIONS: In this cross-sectional study, outpatient adult mental health clinic telepsychiatry appointments, largely by telephone, were strongly associated with a higher rate of visit completion compared with in-person visits during and prior to the COVID-19 pandemic. Regulators should consider permanently enabling reimbursement for telephone-only telepsychiatry visits.


Subject(s)
COVID-19 , Mental Health Services/statistics & numerical data , Psychiatry/methods , Psychiatry/statistics & numerical data , Telemedicine/organization & administration , Telemedicine/statistics & numerical data , Telephone , Adult , COVID-19/epidemiology , Cross-Sectional Studies , Demography , Electronic Health Records , Female , Humans , Male , Middle Aged , Outpatients/statistics & numerical data , Pandemics , Time Factors , United States/epidemiology
4.
Health Aff (Millwood) ; 39(8): 1437-1442, 2020 08.
Article in English | MEDLINE | ID: covidwho-594919

ABSTRACT

New York City Health + Hospitals is the largest safety-net health care delivery system in the United States. Before the coronavirus disease 2019 (COVID-19) pandemic, NYC Health + Hospitals served more than one million patients annually, including the most vulnerable New Yorkers, while billing fewer than five hundred telehealth visits monthly. Once the pandemic struck, we established a strategy to allow us to continue to serve our existing patients while treating the surge of new patients. Starting in March 2020, we were able to transform the system using virtual care platforms through which we conducted almost eighty-three thousand billable televisits in one month, as well as more than thirty thousand behavioral health encounters via telephone and video. Telehealth also enabled us to support patient-family communication, postdischarge follow-up, and palliative care for patients with COVID-19. Expanded Medicaid coverage and insurance reimbursement for telehealth played a pivotal role in this transformation. As we move to a new blend of virtual and in-person care, it is vital that the major regulatory and insurance changes undergirding our COVID-19 telehealth response be sustained to protect access for our most vulnerable patients.


Subject(s)
Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Delivery of Health Care/organization & administration , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Safety-net Providers/organization & administration , Telemedicine/organization & administration , COVID-19 , Coronavirus Infections/prevention & control , Female , Humans , Interdisciplinary Communication , Male , New York City , Outcome Assessment, Health Care , Pandemics/prevention & control , Pneumonia, Viral/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL